186 related articles for article (PubMed ID: 22184754)
1. K12/SECTM1, an interferon-γ regulated molecule, synergizes with CD28 to costimulate human T cell proliferation.
Wang T; Huang C; Lopez-Coral A; Slentz-Kesler KA; Xiao M; Wherry EJ; Kaufman RE
J Leukoc Biol; 2012 Mar; 91(3):449-59. PubMed ID: 22184754
[TBL] [Abstract][Full Text] [Related]
2. Chimeric co-stimulatory molecules that selectively act through CD28 or CTLA-4 on human T cells.
Lazetic S; Leong SR; Chang JC; Ong R; Dawes G; Punnonen J
J Biol Chem; 2002 Oct; 277(41):38660-8. PubMed ID: 12167647
[TBL] [Abstract][Full Text] [Related]
3. The T/NK cell co-stimulatory molecule SECTM1 is an IFN "early response gene" that is negatively regulated by LPS in human monocytic cells.
Huyton T; Göttmann W; Bade-Döding C; Paine A; Blasczyk R
Biochim Biophys Acta; 2011 Dec; 1810(12):1294-301. PubMed ID: 21749909
[TBL] [Abstract][Full Text] [Related]
4. SECTM1 produced by tumor cells attracts human monocytes via CD7-mediated activation of the PI3K pathway.
Wang T; Ge Y; Xiao M; Lopez-Coral A; Li L; Roesch A; Huang C; Alexander P; Vogt T; Xu X; Hwang WT; Lieu M; Belser E; Liu R; Somasundaram R; Herlyn M; Kaufman RE
J Invest Dermatol; 2014 Apr; 134(4):1108-1118. PubMed ID: 24157461
[TBL] [Abstract][Full Text] [Related]
5. Identification of CD7 as a cognate of the human K12 (SECTM1) protein.
Lyman SD; Escobar S; Rousseau AM; Armstrong A; Fanslow WC
J Biol Chem; 2000 Feb; 275(5):3431-7. PubMed ID: 10652336
[TBL] [Abstract][Full Text] [Related]
6. T helper-independent activation of human CD8+ cells: the role of CD28 costimulation.
Van Gool SW; Zhang Y; Kasran A; de Boer M; Ceuppens JL
Scand J Immunol; 1996 Jul; 44(1):21-9. PubMed ID: 8693288
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells.
Kubin M; Kamoun M; Trinchieri G
J Exp Med; 1994 Jul; 180(1):211-22. PubMed ID: 7516408
[TBL] [Abstract][Full Text] [Related]
8. Antagonistic and agonistic anti-canine CD28 monoclonal antibodies: tools for allogeneic transplantation.
Graves SS; Stone DM; Loretz C; Peterson LJ; Lesnikova M; Hwang B; Georges GE; Nash R; Storb R
Transplantation; 2011 Apr; 91(8):833-40. PubMed ID: 21343872
[TBL] [Abstract][Full Text] [Related]
9. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated expression of both the costimulatory CD28 and inhibitory CTLA-4 molecules in PB T cells of advanced cervical cancer patients suggests systemic immunosuppression related to disease progression.
Kosmaczewska A; Bocko D; Ciszak L; Wlodarska-Polinska I; Kornafel J; Szteblich A; Masternak A; Frydecka I
Pathol Oncol Res; 2012 Apr; 18(2):479-89. PubMed ID: 22094905
[TBL] [Abstract][Full Text] [Related]
11. Concanavalin A-mediated T cell proliferation is regulated by herpes virus entry mediator costimulatory molecule.
Ando Y; Yasuoka C; Mishima T; Ikematsu T; Uede T; Matsunaga T; Inobe M
In Vitro Cell Dev Biol Anim; 2014 Apr; 50(4):313-20. PubMed ID: 24163161
[TBL] [Abstract][Full Text] [Related]
12. Evidence implicating the Ras pathway in multiple CD28 costimulatory functions in CD4+ T cells.
Janardhan SV; Praveen K; Marks R; Gajewski TF
PLoS One; 2011; 6(9):e24931. PubMed ID: 21949793
[TBL] [Abstract][Full Text] [Related]
13. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.
Freeman GJ; Lombard DB; Gimmi CD; Brod SA; Lee K; Laning JC; Hafler DA; Dorf ME; Gray GS; Reiser H
J Immunol; 1992 Dec; 149(12):3795-801. PubMed ID: 1281186
[TBL] [Abstract][Full Text] [Related]
14. CTLA-4 ligation suppresses CD28-induced NF-kappaB and AP-1 activity in mouse T cell blasts.
Olsson C; Riesbeck K; Dohlsten M; Michaëlsson E
J Biol Chem; 1999 May; 274(20):14400-5. PubMed ID: 10318864
[TBL] [Abstract][Full Text] [Related]
15. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
Woodward JE; Qin L; Chavin KD; Lin J; Tono T; Ding Y; Linsley PS; Bromberg JS; Baliga P
Transplantation; 1996 Oct; 62(7):1011-8. PubMed ID: 8878397
[TBL] [Abstract][Full Text] [Related]
16. Synergy between CD28 and CD9 costimulation for naive T-cell activation.
Toyo-oka K; Tai XG; Yashiro Y; Ahn HJ; Abe R; Hamaoka T; Kobayashi M; Neben S; Fujiwara H
Immunol Lett; 1997 Jun; 58(1):19-23. PubMed ID: 9436464
[TBL] [Abstract][Full Text] [Related]
17. B7-H5 costimulates human T cells via CD28H.
Zhu Y; Yao S; Iliopoulou BP; Han X; Augustine MM; Xu H; Phennicie RT; Flies SJ; Broadwater M; Ruff W; Taube JM; Zheng L; Luo L; Zhu G; Chen J; Chen L
Nat Commun; 2013; 4():2043. PubMed ID: 23784006
[TBL] [Abstract][Full Text] [Related]
18. Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7.
Damle NK; Klussman K; Leytze G; Myrdal S; Aruffo A; Ledbetter JA; Linsley PS
J Immunol; 1994 Mar; 152(6):2686-97. PubMed ID: 7511623
[TBL] [Abstract][Full Text] [Related]
19. Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors.
Haynes NM; Trapani JA; Teng MW; Jackson JT; Cerruti L; Jane SM; Kershaw MH; Smyth MJ; Darcy PK
Blood; 2002 Nov; 100(9):3155-63. PubMed ID: 12384413
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory drug costimulates T cells via the B7-CD28 pathway.
LeBlanc R; Hideshima T; Catley LP; Shringarpure R; Burger R; Mitsiades N; Mitsiades C; Cheema P; Chauhan D; Richardson PG; Anderson KC; Munshi NC
Blood; 2004 Mar; 103(5):1787-90. PubMed ID: 14512311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
